2021-11-04T13:46:40-07:00 2020-12-31 271661785 CMRosen LLC 17440 Dallas Pkwy Ste 218 Dallas TX 75287 990 2020-01-01 820864340 Cure RTD Foundation CURE 4032444549 6228 Northaven Rd Dallas TX 75230 Melissa Griffith President 2021-11-03 true Melissa Griffith 999009999 Chad M Rosen CPA P01071321 9728181400 2 AAL1 IAL1 FAL1 2020 2022-09-23 18:48:47Z Melissa Griffith 6228 Northaven Rd Dallas TX 75230 257750 false X curertd.org X 2017 TX Primarily to encourage, guide, and fund additional research to improve understanding, diagnosis, and treatment of Riboflavin Transporter Deficiency ("RTD"). 3 3 0 10 0 223484 257468 0 0 165 282 223649 257750 99723 51080 0 0 0 0 622 1890 100345 52970 123304 204780 152670 357450 0 152670 357450 Primarily to encourage, guide, and fund additional research to improve understanding, diagnosis, and treatment of Riboflavin Transporter Deficiency ("RTD"). false false 51100 51080 Cure RTD is proud to have funded the following research projects in advancement of the understanding and treatment of RTD: $32,400 to The University of Texas Southwestern (UTSW) Medical Center for Phase 2 research on developing a gene replacement therapy for RTD. Phase 2 includes safety testing on the newly developed AAV9 viral vector for RTD gene therapy on wild-type mice and also the development of a mouse which carries the RTD mutant genes to be used for future testing. $16,800 to The Children's Hospital at Westmead (CHW) for Phase 2 research on the recently developed RTD animal model using caenorhabditis elegans. This research includes clarifying the underlying mechanism of neuronal injury in RTD and the testing of various therapeutic agents. 51100 true true false false false false false false false false false false false false false false false false false false true true false false false false false true false false false false false false false false false false false false false false false false false false false true 0 0 false 0 false false false false false false false 0 false false false false false false false X 3 3 true false false false false false false true false false false true true false false false false false false false X Melissa Griffith 4032444549 6228 Northaven Rd Dallas TX 75230 X Melissa Griffith President 8.00 0.00 X X 0 0 0 Kristen Greene Secretary 3.00 0.00 X X 0 0 0 Keith Massey Director 40.00 0.00 X 0 0 0 Carly Gilbert Treasurer 8.00 0.00 X 0 0 0 Chad Griffith Fundr Officer 8.00 0.00 X 0 0 0 0 false false false 0 202372 55096 257468 0 0 0 282 282 0 0 0 0 0 0 257750 282 34400 34400 0 16680 16680 0 0 0 0 0 0 0 0 0 0 0 0 0 1842 1842 0 48 20 28 0 0 0 0 0 0 0 0 0 0 0 52970 51100 1870 0 152670 357450 0 0 0 0 0 0 0 0 0 0 0 0 0 0 152670 357450 0 0 X 152670 357450 152670 357450 152670 357450 204780 X false false false X 29456 223484 257468 510408 0 0 29456 223484 257468 510408 0 510408 165 282 447 0 0 510855 X 0.00000 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true East Asia / Pacific 0 0 Grant to agency located there Medical research grant 16680 16680 16680 East Asia / Pac Medical research 16680 Wire Trans 1 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US Periodic reports, along with a detailed final report and analysis with findings, are required for each grant to account for how the grant funds are used. Future grant awards are contingent upon receipt of such reports to ensure that valuable resources are not wasted on research that is not beneficial. Part I, Line 3f - Method of Accounting The expenditures are reported using the cash basis of accounting. Part I, Line 3f - Investments and Expenditures All expenditures consists of research grants awarded to established institutions. Part II, Line 1 - Method of Accounting The expenditures are reported using the cash basis of accounting. true UT Southwestern Medical Ctr 5323 Harry Hines Blvd Dallas TX 75390 756002868 Government 34400 0 Medical research 1 0 Grantmaker's Description of How Grants are Used Periodic reports, along with a detailed final report and analysis with findings, are required for each grant to account for how the grant funds are used. Future grant awards are contingent upon receipt of such reports to ensure that valuable resources are not wasted on research that is not beneficial. Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, Et There is a family relationship between Melissa Griffith and Chad Griffith. Form 990, Part VI, Line 8: Explanation of No Contemporaneously Documentation of Meetings There are no such committees. Form 990, Part VI, Line 11b: Form 990 Review Process A copy of this return was provided to the Organization's President, who in turn forwarded it via email to all Directors for review and approval before filing. Form 990, Part VI, Line 19: Other Organization Documents Publicly Available These documents are available upon request.